The Column Group
VC
INVESTOR TYPE
Active
STATUS
11
PROFESSIONALS
64
INVESTMENTS
23
PORTFOLIO
14
EXITS
Description
The Column Group is a science-driven venture capital investment firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their unique scientific platforms and the potential to deliver multiple breakthrough therapeutics. The firm was founded in 2007 and is headquartered in San Francisco, California.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2007
Primary Investor Type
Venture Capital
Primary Office
- 1700 Owens Street
- Suite 500
- San Francisco, CA 94158
- United States
+1 (415) 000-0000
The Column Group Investments (64)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| eFFECTOR Therapeutics | 13-May-2019 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | 00000000 00000 00.0 |
| 00000000 | 14-Mar-2019 | 00000 00000 | 0000 | Drug Discovery | Startup | 0000000 0000000 00.0 |
| 0000000 0000000000 | 20-Feb-2019 | 00000 00000 | 00000 | Pharmaceuticals | Clinical Trials - Phase 2 | 0000000 0000000 00.0 |
| 00000 000000000000 | 04-Jan-2019 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 1 | 00000 0000000000 |
| 00000000 | 05-Dec-2018 | 00000 00000 | 0000 | Biotechnology | Startup | 0000000 0000000 00.0 |
| 000000 00000000000 | 18-May-2018 | 00000 00000 | 0000 | Drug Delivery | Startup | 00000000 00000 00.0 |
| 0000000 0000000000 | 09-May-2018 | 00000 00000 | 0000 | Biotechnology | Pre-Clinical Trials | 000000 00000 00.0 |
| 0000000000000 0000 | 09-Apr-2018 | 00000 00000 | 00000 | Biotechnology | Clinical Trials - Phase 1 | 00000 0000000 00.0 |
| FLX Bio | 01-Apr-2018 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 00000 0000000 00.0 |
| Revolution Medicines | 23-Mar-2018 | Early Stage VC | 0000 | Biotechnology | Startup | 00000000 00000 00.0 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore The Column Group’s full profile, request a free trial.
The Column Group Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| NGM Biopharmaceuticals | 04-Apr-2019 | IPO | 00000 | Completed |
|
| 000000000 00000000 | 28-Sep-2018 | 000 | 00000 | Completed |
|
| 0000000000000 0000 | 19-Jul-2018 | 000 | 0000 | Completed |
|
| 00000 00000000000 | 15-Mar-2018 | 000 | 00000 | Completed |
|
| 0000000 0000000000 | 27-Oct-2017 | 000 00 00000000 | Completed |
|
|
| 000000 00000000000 | 08-Apr-2015 | 000000000000000000 | 00.000 | Completed |
|
| 0000000 0000000000 | 27-Aug-2014 | 000000000000000000 | 00.000 | Completed |
|
| 000000 000000 | 24-Jul-2014 | 000 | 0000 | Completed |
|
| Cyterix Pharmaceuticals | 01-Jan-2014 | Bankruptcy: Liquidation | Completed |
|
|
| Aragon Pharmaceuticals | 21-Aug-2013 | Merger/Acquisition | 000 | Completed |
The Column Group Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore The Column Group‘s full profile, request access.
Request full access to PitchBookThe Column Group Team (25)
4 Former Team Members
You’re viewing 5 of 25 team members. Get the full list »The Column Group Co-Investors (82)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Topspin Partners | 5 | 0 | 0 |
| Altitude Life Science Ventures | 0 | 0 | |
| EcoR1 Capital | 0 | 0 | 0 |
| NS Investment Partners | 0 | 0 | |
| OrbiMed | 0 | 0 | 0 |